Theodoros Tourountzis

6PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCardiology (incl. cardiovascular diseases)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2025
Lymphocyte Phenotypes and Protein-Bound Uremic Toxins as Determinants of Clinical Outcomes in Hemodialysis Patients.

Theodoros Tourountzis, Georgios Lioulios, Stamatia Stai

|Oct 26, 2024
Hemodiafiltration May Be Associated with Senescence-Related Phenotypic Alterations of Lymphocytes, Which May Predict Mortality in Patients Undergoing Dialysis.

Georgios Lioulios, Asimina Fylaktou, Aliki Xochelli

|Jan 23, 2024
Cardiovascular Events and Mortality in Patients on Hemodialysis: The Prognostic Value of the CHA2DS2-VASc Score.

Theodoros Tourountzis, Georgios Lioulios, Fotini Stasini

|Sep 28, 2023
Immunosenescence and Immune Exhaustion Are Associated with Levels of Protein-Bound Uremic Toxins in Patients on Hemodialysis.

Theodoros Tourountzis, Georgios Lioulios, Steven Van Laecke

|Apr 29, 2023
The prognostic value of CHA2 DS2 -VASc and modified-CHADS2 scores for cardiovascular events in diabetics and non-diabetics haemodialysis patients.

Theodoros Tourountzis, Georgios Lioulios, Evdoxia Ginikopoulou

|Oct 27, 2022
Microbiome in Chronic Kidney Disease.

Theodoros Tourountzis, Georgios Lioulios, Asimina Fylaktou

Pageof 1